Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 3/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 8/20 | 0.37 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.37 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.37 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.34 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20096687 | 0.82 | CACNA1H (0.41) | CACNA1HTRPA1ARCACNA1GCACNA1C | |
| SCHEMBL1635569 | 0.76 | AR (0.40) | CACNA1HTRPA1AR | |
| SCHEMBL1260022 | 0.76 | CACNA1H (0.37) | CACNA1HTRPA1AR | |
| SCHEMBL1636993 | 0.72 | MCHR1 (0.36) | CACNA1HTRPA1ARCACNA1GCACNA1C | |
| SCHEMBL1636643 | 0.72 | AR (0.56) | CACNA1HTRPA1AR | |
| SCHEMBL29935405 | 0.71 | KDM4E (0.54) | TRPA1ARCSNK1DCSNK1G2DGAT1 | |
| SCHEMBL1636551 | 0.71 | AR (0.44) | AR | |
| SCHEMBL4755911 | 0.71 | AR (0.40) | CACNA1HTRPA1AR | |
| SCHEMBL2148589 | 0.70 | AR (0.48) | CACNA1HAR | |
| Lithium SCHEMBL31238632 | 0.70 | KDM4E (0.53) | TRPA1ARCSNK1DCSNK1G2DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018075959-A1 | METHODS USING HDAC11 INHIBITORS | FORMA THERAPEUTICS, INC. (US) | 2018-04-26 | — | — | WO | disclosed |